Back to Studies

P1011 / Serostim Growth Hormone Dose-Finding Study in Children With HIV

A Randomized, Open-label, Dose-Finding Study with Serostim, Mammalian Cell-Derived Recombinant Human Growth Hormone in Children with HIV-Associated Growth Failure

Study Status

Concluded

DAIDS Number

10316

IND Number

60,059

Primary Protocol Team Members

Harland Winter Study Chair
George M. Johnson Study Vice-Chair
Stephen Spector Virologist

Summary

A Randomized, Open-label, Dose-Finding Study with Serostim Mammalian Cell-Derived Recombinant Human Growth Hormone in Children with HIV-Associated Growth Failure

Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...